Blood pressure should be monitored post-treatment Be cautious when using in children less than 5 years of age, and in patients with cardiovascular disease or hyperthyroidism. Rarely, significant elevations in blood pressure may occur.Other warnings and precautions associated with Mydcombi include: Mydcombi is not for injection and is only for topical use in the eye. Mydcombi was FDA approved on May 5th, 2023. Previously, healthcare providers have had to use two separate eye drop preparations. It has been designed to improve the efficiency of office-based comprehensive eye exams and pre-surgery mydriasis (pupil dilation) before cataract surgery.

Mydcombi dilates the pupils in preparation for a diagnostic eye examination or when short-term pupil dilation is required. Mydcombi should not be used by people who are hypersensitive to any of the ingredients contained in the spray. It uses the Optejet dispenser which allows the medication to be delivered horizontally in microdroplets while standing or sitting, unlike traditional eye droppers that rely on gravity, and require a person to have their head tilted back or lying down. Mydcombi contains two common medications routinely used for pupil dilation before a comprehensive eye examination. Mydcombi is a combination eye spray that contains phenylephrine hydrochloride and tropicamide and may be used to dilate the pupils before an eye examination or when short-term pupil dilation is required. Medically reviewed by Carmen Pope, BPharm. Generic name: phenylephrine hydrochloride and tropicamide

Dilated eyes